GlassScriptPhysician profile
Clare M Vander Sluis
NPI 1932988045
$908.32
in general payments reported to CMS, 2019-2025
12 companies · $558 in 2025
The $558 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $350 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629 · Travel and Lodging: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.42 |
| Travel and Lodging | $278.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $278.90 | 2025 | |
| Myriad Genetic Laboratories, INC. | $165.31 | 2024-2025 | Prolaris |
| Boston Scientific Corporation | $130.66 | 2025 | Lithovue |
| Teleflex LLC | $54.81 | 2025 | Barrigel |
| Medtronic, INC. | $52.05 | 2024 | Interstim |
| Procept Biorobotics Corporation | $46.48 | 2025 | |
| Telix Pharmaceuticals | $45.89 | 2024 | Illuccix |
| Smith+Nephew, INC. | $37.05 | 2024 | Stravix |
| Tolmar, INC. | $35.46 | 2024 | |
| Abbvie INC. | $21.44 | 2024 | |
| Novartis Pharmaceuticals Corporation | $21.21 | 2024 | |
| Davol INC. | $19.06 | 2024 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clare Vander Sluis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.